Screener
Xeris Biopharma Holdings, Inc. XERS Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
| Assets | June 30, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 4,834 | 4,945 |
| Operating lease right-of-use assets | 21,773 | 22,112 |
| Goodwill | 22,859 | 22,859 |
| Intangible assets, net | 82,657 | 88,078 |
| Other assets | 5,025 | 5,220 |
| Total assets | $411,905 | $383,527 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Xeris Biopharma Holdings, Inc.'s intangibles (net)?
- Xeris Biopharma Holdings, Inc. (XERS) reported intangibles (net) of $82.66M in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s intangibles (net) changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s intangibles (net) decreased by 11.6% year-over-year, from $93.5M to $82.66M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Xeris Biopharma Holdings, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude